ArticleHaematologica2015

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.

Lars P Jordheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.